Metabolic syndrome and pre-eclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Health
• Metabolic Disorders

Background:

• Pre-eclampsia (PE) is a pregnancy complication associated with long-term cardiovascular risks.
• Different phenotypes of PE may confer varying degrees of postpartum metabolic syndrome risk.

Purpose of the Study:

• To assess the association between distinct pre-eclampsia phenotypes and the development of postpartum metabolic syndrome.
• To identify formerly pre-eclamptic women with a heightened cardiovascular risk profile for tailored follow-up.

Main Methods:

• A cohort study involving 1102 women with a history of pre-eclampsia.
• Women were categorized into four groups based on PE onset (early-onset <34 weeks vs. late-onset ≥34 weeks) and neonate size (small-for-gestational-age vs. appropriate).
• Metabolic syndrome and cardiovascular/cardiometabolic evaluations were performed postpartum.

Main Results:

• Metabolic syndrome prevalence was highest in early-onset PE with small-for-gestational-age neonates (25.8%).
• Early-onset PE with small-for-gestational-age significantly elevated the risk (OR 5.85) compared to late-onset PE.
• History of small-for-gestational-age, early-onset PE, and systolic blood pressure were key predictors of postpartum metabolic syndrome.

Conclusions:

• Postpartum metabolic syndrome risk is significantly higher with early-onset pre-eclampsia combined with small-for-gestational-age neonates.
• Both the timing of pre-eclampsia onset and fetal growth critically influence the risk of developing metabolic syndrome post-pregnancy.